Association of Self‐Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education
Neuropsychopharmacology Reports · 2026-12 · 46 (4)
DOI: 10.1002/npr2.70179 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 03.11.2026. Verfasst von Kazuhiko Yamamuro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Control, Nara Medical University, Kashihara, Japan. Hauptthemen laut MEDLINE: Major Depressive Disorder, Schizophrenia, Guideline Adherence, Self Report. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science KAKENHI, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Background
The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project is a nationwide Japanese educational program promoting guideline‐concordant pharmacotherapy for schizophrenia and major depressive disorder (MDD). Psychiatrists' self‐reported clinical behavior (CB) scores after EGUIDE training are partially associated with objective quality indicators of specific practices. However, their association with comprehensive objective measures of overall guideline adherence remains unclear.
Methods
This multicenter observational study included 1897 EGUIDE‐trained psychiatrists. CB was assessed online immediately after training. The Guideline Adherence Rate (GAR) was calculated for 5328 patients with schizophrenia and 3538 patients with MDD whose discharge records were linked to their psychiatrist's CB score. Associations were evaluated using unadjusted patient‐level Spearman correlations, without modeling clustering within psychiatrists or institutions. Sensitivity analyses aggregated the data to the psychiatrist‐year level, adjusted for institution type, psychiatrist experience, and patient age, and used generalized estimating equations (GEE) to correct the patient‐level inference for clustering.
Results
CB scores showed positive but very weak correlations with GAR (schizophrenia, ρ = 0.09–0.14; MDD, ρ = 0.08–0.11; all p < 0.001). Squared coefficients (approximately 0.006–0.020) indicated that CB scores accounted for < 2% of the rank‐order variation in GAR. These associations remained statistically significant in psychiatrist‐year‐level, covariate‐adjusted, and clustering‐corrected (GEE) sensitivity analyses.
Conclusions
Post‐training self‐reported CB scores were weakly associated with patient‐level GAR. Given the cross‐sectional, unadjusted analysis and the non‐independence of patients treated by the same psychiatrist, these findings do not establish CB as a reliable proxy for actual clinical practice. Trial Registration University Hospital Medical Information Network Clinical Trials Registry, UMIN000022645
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Health Control, Nara Medical University, Kashihara, Japan.
- Department of Psychiatry, School of Medicine, Nara Medical University, Kashihara, Japan.
- Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
- Department of Neuropsychiatry, Kyorin University School of Medicine, Mitaka, Japan.
- Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Toon, Japan.
- Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
ORCID-Profile: Kazuhiko Yamamuro, Hikaru Hori, Takashi Tsuboi, Shinichiro Ochi, Toru Horinouchi, Yasushi Kawamata, Keisuke Mori, Yusuke Arai, Kazutaka Ohi, Junya Matsumoto, Toshiaki Onitsuka, Koichiro Watanabe, Ken Inada, Norio Yasui-Furukori, Ryota Hashimoto
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science KAKENHI
- Ministry of Health, Labour and Welfare
- Japanese Society of Neuropsychopharmacology
- Japanese Society of Mood Disorders
- Japanese Society of Clinical Neuropsychopharmacology
- Japanese Society of Psychiatry and Neurology
Zitieren
APA
Yamamuro, K., Hori, H., Tsuboi, T., Ochi, S., Horinouchi, T., Kawamata, Y., Mori, K., Arai, Y., Ohi, K., Matsumoto, J., Onitsuka, T., Watanabe, K., Inada, K., Yasui-Furukori, N., & Hashimoto, R. (2026). Association of Self‐Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education. Neuropsychopharmacology Reports, 46(4). https://doi.org/10.1002/npr2.70179
Vancouver
Yamamuro K, Hori H, Tsuboi T, Ochi S, Horinouchi T, Kawamata Y, et al. Association of Self‐Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education. Neuropsychopharmacology Reports. 2026;46(4). doi:10.1002/npr2.70179
BibTeX
@article{Yamamuro2026,
author = {Yamamuro, Kazuhiko and Hori, Hikaru and Tsuboi, Takashi and Ochi, Shinichiro and Horinouchi, Toru and Kawamata, Yasushi and Mori, Keisuke and Arai, Yusuke and Ohi, Kazutaka and Matsumoto, Junya and Onitsuka, Toshiaki and Watanabe, Koichiro and Inada, Ken and Yasui-Furukori, Norio and Hashimoto, Ryota},
title = {Association of Self‐Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education},
journal = {Neuropsychopharmacology Reports},
year = {2026},
volume = {46},
number = {4},
doi = {10.1002/npr2.70179}
}
EUVIMED